移码突变
遗传学
生物
生物信息学
促性腺激素减退症
表型
小基因
遗传变异
损失函数
RNA剪接
卡尔曼综合征
人类遗传学
突变
外显子组测序
遗传变异
医学遗传学
外显子跳跃
外显率
生物信息学
基因
成纤维细胞生长因子受体1
基因检测
功能(生物学)
外显子
遗传咨询
计算生物学
表现力
作者
Yuting Li,Pingchuan Zhang,Jun Guan,Chengli He,Jianglan Fu,Ruizhi Zheng,Danna Chen,Xiong Tang,Meichao Men,Zhiheng Chen,Jia‐Da Li
摘要
To determine the prevalence of CHD7, FGFR1 and ANOS1 variants and the impacts of their splicing variants on mis-splicing in patients with congenital hypogonadotropic hypogonadism (CHH). Based on the whole-exome sequencing data from 280 CHH probands, we identified 15 potential splice-site variants in CHD7, ANOS1 and FGFR1 by using in silico software. The functional consequences of these variants were analyzed by the minigene assay or RT-PCR analyses of RNA taken from the peripheral lymphocytes. Detailed phenotyping was performed in the CHH patients harboring deleterious variants and their available family members. 11 out of 15 potential splice-site variants were demonstrated to cause mis-splicing, resulting in loss of function through deletion, insertion or frameshift of amino acids in the proteins. Most patients with deleterious splice-site variants in CHD7, ANOS1, FGFR1 presented with gene-specific non-reproductive phenotypes, confirming the pathogenic contribution of these variants to CHH. Our study indicated that splice-site variants in CHD7, ANOS1, FGFR1 underlie the genetic basis of ~3.9% of CHH patients, warranting the inclusion of potential splice-site variants for genetic diagnosis and counseling of CHH.
科研通智能强力驱动
Strongly Powered by AbleSci AI